Skip to main content

Caspases participation in cell death induced by the GD2-specific antibodies

Russian Journal of Bioorganic Chemistry volume 40, pages 279–287 (2014)Cite this article

Abstract

Contribution of the main caspases in cytotoxic effects induced by the monoclonal antibody 14G2a specific to the tumor-associated ganglioside GD2 was studied in the EL-4 mouse lymphoma cells. The constitutive expression of the procaspase genes was found in the EL-4 cells. Incubation of the cells with the 14G2a antibodies did not result in increasing of the procaspase synthesis. We also demonstrated with the use of fluorescently labeled substrates of caspases that the procaspase enzymatic activity was not enhanced. At an equal level of cell death, activities of caspase-3 and caspase-9 in the cells which were incubated with the 14G2a antibodies were 7.5 and 3 times lower, respectively, than those in the staurosporine-treated cells. The pan-caspase inhibitor (Z-VAD-FMK) and the caspase-3 inhibitor decreased the cytotoxic effects induced by the 14G2a antibodies by 9–16 and 6–13%, respectively. The staurosporine-induced level of the apoptosis decreased by 55–65% under the same conditions. Inhibitors of the initiation caspase-8 and caspase-9 had no influence on the antibody-induced cell death. The inhibitory analysis also demonstrated that the caspases were not involved in the triggering of the initial stages of the antibody-induced cell death such as apoptotic volume decrease and permeabilization of the cell plasma membrane. Thus, caspases did not play a key role in the cell death induced by the anti-GD2 antibodies, and their slight enzymatic activity did not determine the main mechanism of cell death mediated through the tumor-associated ganglioside GD2.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Abbreviations

7-AAD:

7-aminoactinomycin D

AVD:

apoptotic volume decrease

FBS:

fetal bovine serum

MTT:

3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide

FITC:

Fluorescein isothiocyanate

HEPES:

2-[4-(2-hydroxyethyl)piperazine-1-yl]ethylsulfonic acid

PI:

propidium iodide

siRNA:

small interfering RNA

Z-VAD-FMK:

pan-caspase inhibitor

Z-DEVD-FMK/AFC:

inhibitor/substrate of caspase-3

Z-IETD-FMK/AFC:

inhibitor/substrate of caspase-8

Z-LEHD-FMK/AFC:

inhibitor/substrate of caspase-9

anti-GD2-mAb:

GD2-specific monoclonal antibody

PBS:

phosphate buffered saline

References

  1. Ritter, G. and Livingston, P.O., Semin. Cancer Biol., 1991, vol. 2, pp. 401–409.

    CAS  PubMed  Google Scholar 

  2. Cheung, N.K. and Dyer, M.A., Nat. Rev. Cancer, 2013, vol. 13, no. 6, pp. 397–411.

    CAS  PubMed  Article  Google Scholar 

  3. Navid, F., Armstrong, M., and Barfield, R.C., Cancer Biol. Ther., 2009, vol. 8, no. 10, pp. 874–882.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  4. Vodovozova, E.L., Nazarova, A.I., Feofanov, A.V., Kholodenko, R.V., Pazynina, G.V., Gaenko, G.P., Bovin, N.V., and Molotkovsky, Yul.G., Biol. Membr., 2004, vol. 21, p. 53.

    CAS  Google Scholar 

  5. Di Paolo, D., Brignole, C., Pastorino, F., Carosio, R., Zorzoli, A., Rossi, M., Loi, M., Pagnan, G., Emionite, L., Cilli, M., Bruno, S., Chiarle, R., Allen, T.M., Ponzoni, M., and Perri, P., Mol. Ther., 2011, vol. 19, no. 6, pp. 1131–1140.

    PubMed Central  PubMed  Article  Google Scholar 

  6. Kholodenko, I.V., Doronin, I.I., and Kholodenko, R.V., Sovr. Probl. Dermatovenerol. Immunol. Vracheb. Kosmetol., 2010, vol. 6, pp. 79–83.

    Google Scholar 

  7. Mujoo, K., Kipps, T.J., Yang, H.M., Cheresh, D.A., Wargalla, U., Sander, D.J., and Reisfeld, R.A., Cancer Res., 1989, vol. 49, no. 11, pp. 2857–2861.

    CAS  PubMed  Google Scholar 

  8. Kowalczyk, A., Gil, M., Horwacik, I., Odrowaz, Z., Kozbor, D., and Rokita, H., Cancer Lett., 2009, vol. 281, no. 2, pp. 171–182.

    CAS  PubMed  Article  Google Scholar 

  9. Yoshida, S., Kawaguchi, H., Sato, S., Ueda, R., and Furukawa, K., Japan J. Cancer Res., 2002, vol. 93, no. 7, pp. 816–824.

    CAS  Article  Google Scholar 

  10. Kholodenko, R.V., Sovr. Probl. Dermatovenerol. Immunol. Vracheb. Kosmetol., 2010, vol. 1, pp. 13–19.

    Google Scholar 

  11. Kholodenko, I.V., Doronin, I.I., Vishnyakova, P.A., Bolkhovitina, E.L., Molotkovskaya, I.M., and Kholodenko, R.V., Immunologiya, 2013, vol. 34, no. 4, pp. 199–203.

    Google Scholar 

  12. Kroemer, G., Galluzzi, L., Vandenabeele, P., Abrams, J., Alnemri, E.S., Baehrecke, E.H., Blagosklonny, M.V., El-Deiry, W.S., Golstein, P., Green, D.R., Hengartner, M., Knight, R.A., Kumar, S., Lipton, S.A., Malorni, W., Nunez, G., Peter, M.E., Tschopp, J., Yuan, J., Piacentini, M., Zhivotovsky, B., and Melino, G., Cell Death. Differ., 2009, vol. 16, no. 1, pp. 3–11.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  13. Miura, M., Cold Spring Harb. Perspect. Biol., 2012, doi: 10, 1101/cshperspect.a008664.

    Google Scholar 

  14. Telford, W.G., King, L.E., and Fraker, P.J., J. Immunol. Methods, 1994, vol. 172, no. 1, pp. 1–16.

    CAS  PubMed  Article  Google Scholar 

  15. Cheung, N.K., Guo, H., Hu, J., Tassev, D.V., and Cheung, I.Y., Oncoimmunology, 2012, vol. 1, no. 4, pp. 477–486.

    PubMed Central  PubMed  Article  Google Scholar 

  16. Chae, H.J., Kang, J.S., Byun, J.O., Han, K.S., Kim, D.U., Oh, S.M., Kim, H.M., Chae, S.W., and Kim, H.R., Pharmacological Res., 2000, vol. 42, no. 4, pp. 373–381.

    CAS  Article  Google Scholar 

  17. Fink, D., Schlagbauer-Wadl, H., Selzer, E., Lucas, T., Wolff, K., Pehamberger, H., Eichler, H.G., and Jansen, B., Melanoma Res., 2001, vol. 11, no. 4, pp. 385–393.

    CAS  PubMed  Article  Google Scholar 

  18. Sakahira, H., Enari, M., and Nagata, S., Nature, 1998, vol. 391, no. 6662, pp. 96–99.

    CAS  PubMed  Article  Google Scholar 

  19. Bortner, C.D. and Cidlowski, J.A., Cell Physiol. Biochem., 2011, vol. 28, no. 6, pp. 1079–1088.

    CAS  PubMed Central  PubMed  Article  Google Scholar 

  20. Vishnyakova, P.A., Kholodenko, I.V., Molotkovskaya, I.M., and Kholodenko, R.V., Front. Immunol., 2013, ICI Conference Abstract. doi: 10.3389/conf.fimmu. 2013.02.00284

    Google Scholar 

  21. Molotkovskaya, I.M., Kholodenko, R.V., Zelenova, N.A., Sapozhnikov, A.M., Mikhalev, I.I., and Molotkovsky, Jul.G., Membr. Cell Biol., 2000, vol. 13, pp. 811–822.

    CAS  PubMed  Google Scholar 

  22. Kholodenko, R.V., Sapozhnikov, A.M., Mikhalev, I.I., Molotkovsky, Yul.G., and Molotkovskaya, I.M., Biol. Membr., 2002, vol. 19, pp. 209–215.

    CAS  Google Scholar 

  23. Kholodenko, R.V., Kholodenko, I.V., Viskova, N.Yu., Lutsan, N.I., and Molotkovskaya, I.M., Biol. Membr., 2007, vol. 24, pp. 142–149.

    CAS  Google Scholar 

  24. Vishnyakova, P.A. and Kholodenko, R.V., Vopr. Biol. Med. Farmats. Khim., 2013, no. 6, pp. 4–6.

    Google Scholar 

  25. Doronin, I.I., Kholodenko, I.V., Molotkovskaya, I.M., and Kholodenko, R.V., Bull. Exp. Biol. Med., 2013, vol. 154, pp. 658–663.

    CAS  PubMed  Article  Google Scholar 

  26. Denizot, F. and Lang, R., J. Immunol. Methods, 1986, vol. 89, no. 2, pp. 271–277.

    CAS  PubMed  Article  Google Scholar 

  27. Konieva, A.A., Kholodenko, I.V., Shragina, O.A., Kholodenko, R.V., Burunova, V.V., Bibaeva, L.V., Yarygin, K.N., and Yarygin, V.N., Bull. Exp. Biol. Med., 2010, vol. 150, pp. 131–136.

    CAS  PubMed  Article  Google Scholar 

  28. Kholodenko, R., Kholodenko, I., Sorokin, V., Tolmazova, A., Sazonova, O., and Buzdin, A., Cell Res., 2007, vol. 17, no. 2, pp. 151–162.

    CAS  PubMed  Article  Google Scholar 

  29. Kholodenko, I.V., Buzdin, A.A., Kholodenko, R.V., Baibikova, J.A., Sverdlov, E.D., Sorokin, V.F., and Yarygin, V.N., Biochemistry (Moscow), 2006, vol. 71, pp. 767–774.

    CAS  Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, ul. Miklukho-Maklaya 16/10, Moscow, 117997, Russia

    P. A. Vishnyakova, I. I. Doronin, I. V. Kholodenko, D. Yu. Ryazantsev, I. M. Molotkovskaya & R. V. Kholodenko

  2. Orekhovich Institute of Biomedical Chemistry, Russian Academy of Medical Sciences, ul. Pogodinskaya 10, str. 8, Moscow, 119121, Russia

    I. V. Kholodenko

Authors
  1. P. A. Vishnyakova
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. I. I. Doronin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. I. V. Kholodenko
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. D. Yu. Ryazantsev
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. I. M. Molotkovskaya
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. R. V. Kholodenko
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R. V. Kholodenko.

Additional information

Original Russian Text © P.A. Vishnyakova, I.I. Doronin, I.V. Kholodenko, D.Yu. Ryazantsev, I.M. Molotkovskaya, R.V. Kholodenko, 2014, published in Bioorganicheskaya Khimiya, 2014, Vol. 40, No. 3, pp. 305–314.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Vishnyakova, P.A., Doronin, I.I., Kholodenko, I.V. et al. Caspases participation in cell death induced by the GD2-specific antibodies. Russ J Bioorg Chem 40, 279–287 (2014). https://doi.org/10.1134/S1068162014030157

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S1068162014030157

Keywords

  • GD2
  • tumor-associated gangliosides
  • caspases
  • cell death
  • apoptosis
  • monoclonal antibodies